848
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Cancer risk is not increased after conventional hip arthroplasty

A nationwide study from the Finnish Arthroplasty Register with follow-up of 24,636 patients for a mean of 13 years

, , &
Pages 77-81 | Received 15 May 2009, Accepted 05 Oct 2009, Published online: 23 Feb 2010

  • Anttila A, Pukkala E, Aitio A, Rantanen T, Karjalainen S. Update of cancer incidence among workers at a copper/nickel smelter and nickel refinery. Int Arch Occup Environ Health 1998;71:245-50.
  • Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000; 60:1619-25.
  • Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap PF, Solomon L. Widespread dissemination of metal debris from implants. J Bone Joint Surg (Br) 1994; 76:701-12.
  • Case CP, Langkamer VG, Howell RT, Webb J, Standen G, Palmer M, Kemp A, Learmonth ID. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop 1996; 329 (Suppl) S: 269-79.
  • Coen N, Kadhim MA, Wright EG, Case CP, Mothersill CE. Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells. Br J Cancer 2003; 88:548-52.
  • Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M, Coggon D. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 1998; 15;147: 516-22.
  • Daley B, Doherty AT, Fairman B, Case CP. Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg (Br) 2004; 86:598-606.
  • Davies AP, Sood A, Lewis AC, Newson R, Learmonth ID, Case CP. Metal-specific differences in levels of DNA damage caused by synovial fluid recovered at revision arthroplasty. J Bone Joint Surg (Br) 2005; 87:1439-44.
  • Doherty AT, Howell RT, Ellis LA, Bisbinas I, Learmonth ID, Newson R, Case CP. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip. J Bone Joint Surg (Br) 2001; 83:1075-81.
  • Engh CA Jr, Moore KD, Vinh TN, Engh GA. Titanium prosthetic wear debris in remote bone marrow. A report of two cases. J Bone Joint Surg (Am) 1997; 79:1721-5.
  • Gatti GM, Ivaldi GB, Lartigau E, Marsiglia H, Orecchia R. A case of rhabdomyosarcoma following metal surgical implant. Sarcoma 1999; 3:145-7.
  • Gillespie WJ, Frampton CM, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J Bone Joint Surg (Br): 1988; 70: 539-42. Erratum in: J Bone Joint Surg (Br) 1996; 78:680.
  • Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancer following hip and knee arthroplasty: record linkage study. Br J Cancer 2005; 92:1298-301.
  • Granchi D, Savarino L, Ciapetti G, Cenni E, Rotini R, Mieti M, Baldini N, Giunti A. Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg (Br) 2003; 85:758-64.
  • Hsieh TC, Kao CH, Yen KY, Sun SS. Osteomyelitis-mimicking primary bone lymphoma at hip prosthetic site. Clin Nucl Med 2007; 32:543-4.
  • Jacobs JJ, Skipor AK, Patterson LM, Hallab NJ, Paprosky WG, Black J, Galante JO. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg (Am) 1998; 80:1447-58.
  • Järvholm B, Lewold S, Malchau H, Vingard E. Age, bodyweight, smoking habits and the risk of severe osteoarthritis in the hip and knee in men. Eur J Epidemiol 2005; 20:537-42.
  • Langkamer VG, Case CP, Heap P, Taylor A, Collins C, Pearse M, Solomon L. Systemic distribution of wear debris after hip replacement. A cause for concern. J Bone Joint Surg (Br) 1992; 74:831-9.
  • Lucas DR, Miller PR, Mott MP, Kronick JL, Unni KK. Athroplasty-associated malignant fibrous histiocytoma: two case reports. Histopathology 2001; 39:620-8 Review.
  • MacDonald SJ, McCalden RW, Chess DG, Bourne RB, Rorabeck CH, Cleland D, Leung F. Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin Orthop 2003; (406):282-96.
  • Min WK, Kim SY, Oh CW Kim SJ Park TI, Koo KH. Malignant fibrous histiocytoma arising in the area of total hip replacement. J Bone Spine 2008; 75:319-21.
  • Nevalainen J, Hirvonen A, Pulkkinen P. The 1998-1999 implant yearbook on orthopaedic endoprostheses. Publication of the National Agency for Medicines, Helsinki 5/2000.
  • Onega T, Baron J, MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1532-7.
  • Paavolainen P, Pukkala E, Pulkkinen , Visuri T. . Cancer incidence in Finnish hip replacement patients from 1980 to 1995. A nationwide cohort study involving 31,651 patients. J. Arthroplasty 1999; 14: 272-80. Erratum 2000; 15: 136-7.
  • Papageorgiou I, Shadrick V, Davis S, Hails L, Schins R, Newson R, Fisher J, Ingham E, Case CP. Macrophages detoxify the genotoxic and cytotoxic effects of surgical cobalt chrome alloy particles but not quartz particles on human cells in vitro. Mutat Res 2008; 643(1-2):11-9.
  • Rasquinha VJ, Ranawat CS, Weiskopf J, Rodriguez JA, Skipor AK, Jacobs JJ. Serum metal levels and bearing surfaces in total hip arthroplasty. J Arthroplasty 2006; 21(6 Suppl 2):47-52.
  • Reynolds M, Peterson E, Quievryn G, Zhitkovich A. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J Biol Chem 2004; 279:30419-24.
  • Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi CA, Baldini N, Giunti A. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002; 63:467-74.
  • Schuh A, Zeiler G, Holzwarth U, Aigner T. Malignant fibrous histiocytoma at the site of a total hip arthroplasty. Cin Orthop 2004; (425): 218-22, Review.
  • Shea KG, Lundeen GA, Bloebaum RD, Bachus KN, Zou L. Lymphoreticular dissemination of metal particles after primary joint replacements. Clin Orthop 1997; (338):219-26.
  • Stea S, Visentin M, Granchi D, Savarino L, Dallari D, Gualtieri G, Rollo G, Toni A, Pizzoferrato A, Montanaro L. Sister chromatid exchange in patients with joint prosthesis. J Arthroplasty 2000; 15:772-7.
  • Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000; 88:497-502.
  • Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003; 4: 45-55, Review. Erratum in: Lancet Oncol 2003; 4: 396.
  • Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc’h M. Dissemination of wear particles to the liver, spleen and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg (Am) 2000; 82:457-76.
  • Urban RM, Tomlinson MJ, Hall DJ, Jacobs JJ. Accumulation in liver and spleen of metal particles generated at nonbearing surfaces in hip arthroplasty. J Arthroplasty 2004; 19(Suppl 3):94-101.
  • Vingård E, Alfredsson L, Malchau H. Lifestyle factors and hip arthrosis. A case referent study of body mass index, smoking and hormone therapy in 503 Swedish women. Acta Orthop Scand 1997; 68:216-20.
  • Visuri T, Pukkala E, Pulkkinen P, Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: a meta-analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand 2003; 74:351-60.
  • Visuri T, Koskenvuo M. Cancer risk after Mckee-Farrar total hip replacement. Orthopedics 1991; 14:137-42.
  • Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Arthroplasty 2006; 21:311-23.
  • zur Hausen H Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-78, Review.
  • Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases Thorax 1997; 52: 507-12, Erratum Thorax 1997; 52:1018.